Aligos therapeutics to present at investor conferences in october

South san francisco, calif., sept. 30, 2024 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will participate at two investor conferences being webcast in october:
ALGS Ratings Summary
ALGS Quant Ranking